Lipid changes in HIV-patients switching to the coformulated single tablet FTC/RPV/TDF (Eviplera®). Efficacy and safety analysis. GeSida Study 8114.

Pérez-Hernández, Isabel A; Palacios, Rosario; Mayorga, Marisa; González-Doménech, Carmen M; Castaño, Manuel; Rivero, Antonio; Del Arco, Alfonso; Lozano, Fernando; Santos, Jesús.

Afiliação

Pérez-Hernández IA; Infectious Diseases, Hospital Virgen de la Victoria, Malaga, Spain.
Palacios R; Infectious Diseases, Hospital Virgen de la Victoria, Malaga, Spain.
Mayorga M; Infectious Diseases, Hospital Carlos Haya, Malaga, Spain.
González-Doménech CM; Infectious Diseases, Hospital Virgen de la Victoria, Malaga, Spain.
Castaño M; Infectious Diseases, Hospital Carlos Haya, Malaga, Spain.
Rivero A; Infectious Diseases, Hospital Reina Sofía, Cordoba, Spain.
Del Arco A; Internal Medicine, Hospital Costa del Sol, Marbella, Spain.
Lozano F; Infectious Diseases, Hospital Valme, Sevilla, Spain.
Santos J; Infectious Diseases, Hospital Virgen de la Victoria, Malaga, Spain.

J Int AIDS Soc ; 17(4 Suppl 3): 19795, 2014.

Article em En | MEDLINE | ID: mdl-25397539

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article